
    
      Iodixanol, a nonionic, dimeric, iso-osmolar contrast medium (IOCM), may be less nephrotoxic
      than nonionic, monomeric, low-osmolar contrast media (LOCMs) in high-risk patients. We
      compared the nephrotoxicity of iodixanol with that of ioxaglate, an ionic, dimeric LOCM, in
      patients with renal impairment.
    
  